Know your World in Just 60 Words!
Read news in 1 minute
Hot Topics
Select the content to hear the Audio

Added on : 2020-11-22 06:58:25

Bharat Biotech has confirmed that its potential COVID-19 vaccine COVAXIN reported an adverse event during the Phase 1 clinical trials in August. "The adverse event was investigated thoroughly and determined as not vaccine-related," Bharat Biotech said in a statement. As per reports, the adverse event occurred in a 35-year-old participant with no co-morbidities who was hospitalised.
 

UNLOCK 5.0

Headlines

Good News

politics

India

World

Copyright © 2019 Newz Viewz | Created by Communicators and Developed by Seawind Solution Pvt. Ltd.